Akira Kawai Selected Research

Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))

11/2022	Prognostic impact of IDH mutations in chondrosarcoma.
6/2022	Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma.
10/2019	Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akira Kawai Research Topics

Disease

140	Neoplasms (Cancer) 05/2024 - 01/2002
80	Sarcoma (Soft Tissue Sarcoma) 05/2024 - 04/2002
43	Neoplasm Metastasis (Metastasis) 01/2024 - 07/2004
28	Osteosarcoma (Osteogenic Sarcoma) 06/2023 - 08/2008
23	Synovial Sarcoma (Synovioma) 10/2023 - 04/2002
12	Chondrosarcoma 11/2022 - 01/2002
10	Infections 10/2023 - 05/2010
10	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2013 - 08/2004
7	Liposarcoma 05/2024 - 02/2017
6	Leiomyosarcoma 05/2024 - 08/2004
6	Ewing Sarcoma (Sarcoma, Ewing) 02/2024 - 04/2009
6	Disease Progression 02/2024 - 04/2015
5	Rhabdomyosarcoma 04/2024 - 09/2011
5	Dermatofibrosarcoma 02/2024 - 09/2010
5	Margins of Excision 10/2023 - 01/2014
5	Neurofibrosarcoma (MPNST) 04/2023 - 09/2008
5	Alveolar Soft Part Sarcoma 08/2022 - 05/2014
5	Giant Cell Tumor of Bone 06/2022 - 06/2009
4	Carcinogenesis 01/2021 - 01/2002
4	Aggressive Fibromatosis (Desmoid) 10/2020 - 08/2004
4	Fibroma (Fibromatosis) 10/2020 - 08/2004
4	Necrosis 01/2016 - 09/2011
3	Myxoid Liposarcoma 12/2023 - 04/2019
3	Breast Neoplasms (Breast Cancer) 06/2023 - 09/2014
3	Extraskeletal Myxoid Chondrosarcoma 05/2023 - 01/2016
3	Neutropenia 11/2022 - 10/2020
3	Giant Cell Tumors (Giant Cell Tumor) 01/2022 - 01/2016
3	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 01/2018 - 08/2003
2	Inflammation (Inflammations) 05/2024 - 10/2014
2	Wounds and Injuries (Trauma) 12/2023 - 01/2022
2	Hip Dislocation 10/2023 - 01/2003
2	Esophageal Neoplasms (Esophageal Cancer) 09/2023 - 07/2023
2	Chordoma 02/2023 - 03/2016
2	Brain Diseases (Brain Disorder) 01/2023 - 01/2023
2	Fibrosarcoma 01/2023 - 01/2019
2	Emergence Delirium 11/2022 - 01/2021
2	Pneumothorax 10/2022 - 05/2016
2	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2022 - 07/2022

Drug/Important Bio-Agent (IBA)

28	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2006
26	Proteins (Proteins, Gene)FDA Link 07/2022 - 04/2002
16	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 05/2005
12	pazopanib FDA Link 10/2023 - 03/2016
11	TrabectedinIBA 05/2024 - 08/2014
11	MicroRNAs (MicroRNA)IBA 06/2023 - 06/2011
8	Ifosfamide FDA LinkGeneric 01/2023 - 05/2005
7	Phosphotransferases (Kinase)IBA 01/2023 - 05/2005
7	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2017
6	eribulin FDA Link 06/2023 - 01/2017
6	Keratins (Keratin)IBA 05/2023 - 08/2003
6	ProteomeIBA 04/2023 - 01/2012
5	S100 Proteins (S 100 Protein)IBA 01/2023 - 08/2003
4	Imatinib Mesylate (Gleevec)FDA Link 02/2024 - 09/2010
4	Platelet-Derived Growth FactorIBA 02/2024 - 01/2019
4	AnthracyclinesIBA 10/2023 - 01/2018
4	Antineoplastic Agents (Antineoplastics)IBA 06/2023 - 08/2014
4	Gemcitabine FDA Link 11/2022 - 08/2014
4	Denosumab FDA Link 06/2022 - 01/2016
4	Monoclonal AntibodiesIBA 01/2022 - 01/2010
4	Mucin-1 (CA 15-3 Antigen)IBA 12/2019 - 08/2003
3	Small Interfering RNA (siRNA)IBA 12/2023 - 01/2016
3	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 11/2023 - 01/2019
3	AntigensIBA 10/2023 - 08/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 05/2005
3	Indicators and Reagents (Reagents)IBA 06/2023 - 01/2020
3	tyrosine receptor (receptor, tyrosine)IBA 01/2023 - 05/2005
3	Peptides (Polypeptides)IBA 01/2023 - 08/2002
3	Docetaxel (Taxotere)FDA Link 11/2022 - 08/2014
3	alpha-hydroxyglutarateIBA 11/2022 - 10/2019
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2022 - 10/2019
3	Messenger RNA (mRNA)IBA 01/2020 - 09/2014
3	DesminIBA 12/2019 - 08/2003
3	Contrast MediaIBA 01/2018 - 03/2006
3	OligonucleotidesIBA 11/2010 - 07/2007
2	Collagen Type I (Type I Collagen)IBA 02/2024 - 11/2023
2	Dasatinib (BMS 354825)FDA Link 10/2023 - 04/2013
2	Histones (Histone)IBA 02/2023 - 11/2021
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 03/2021
2	Aprepitant (Emend)FDA Link 01/2023 - 01/2023
2	Yi-Gan SanIBA 11/2022 - 01/2021
2	Angiogenesis InhibitorsIBA 10/2022 - 03/2009
2	Glial Fibrillary Acidic ProteinIBA 01/2022 - 08/2015

Therapy/Procedure

55	Drug Therapy (Chemotherapy) 02/2024 - 05/2005
43	Therapeutics 04/2024 - 01/2002
19	Radiotherapy 02/2024 - 02/2007
10	Prostheses and Implants (Prosthesis) 08/2023 - 08/2008
10	Limb Salvage 08/2023 - 10/2005
9	Surgical Amputation (Amputations) 12/2023 - 03/2003
8	Adjuvant Chemotherapy 12/2023 - 12/2015
8	Neoadjuvant Therapy 09/2023 - 07/2009
5	Curettage 06/2022 - 10/2005
3	Myocutaneous Flap 08/2023 - 03/2016
3	Aftercare (After-Treatment) 02/2022 - 10/2012
3	Induction Chemotherapy 01/2016 - 02/2007
2	Operative Surgical Procedures 10/2023 - 02/2019
2	Disarticulation 10/2023 - 10/2005
2	Esophagectomy 09/2023 - 07/2023
2	Immunotherapy 01/2023 - 03/2021
2	Combined Modality Therapy 01/2023 - 01/2020
2	Metastasectomy 07/2022 - 07/2021